Exponent, Inc. Buyback
OLI recorded this information on 2/1/2024
Company:
Exponent, Inc.
Buyback:
EXPO buyback
$Amount Authorized:
$100,000,000
Buyback Details:
Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has raised its quarterly dividend from $0.26 to $0.28 per share of common stock. The quarterly cash dividend of $0.28 per share of common stock is to be paid on March 22, 2024 to all common stockholders of record as of March 8, 2024. "This is the 11th consecutive year of increasing our regular quarterly cash dividend. Additionally, our Board of Directors approved an increase of $61.6 million to our current stock repurchase authorization bringing our total authorization to $100 million, further illustrating their confidence in the business's long-term trajectory," commented Dr. Catherine Corrigan, President and Chief Executive Officer. "Exponent is proud to execute on our commitment to delivering long-term value for our shareholders. In 2023, we returned $78.2 million to shareholders through $54.0 million in dividends and $24.2 million in common stock repurchases, while ending the year with $187.2 million in cash and cash equivalents."
Exponent is a science and engineering consulting firm. Co. operates various practices in two reportable operating segments, Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a service group providing technical consulting in different practices primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a range of consulting services relating to environmental hazards and risks and the impact on both human health and the environment.
EXPO SEC Filing Email Alerts Service
Open the EXPO Page at The Online Investor »
|
||||||||||||||||||||||||
Open the EXPO Page at The Online Investor (in a new window) »
 Free EXPO Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
  
|
Buy (2.67 out of 4) 12nd percentile
(ranked lower than approx. 88% of all stocks covered)
Analysts' Target Price: EXPO Stock Forecast Based on Zacks ABR data; powered by Xignite |
